TTNP
Titan Pharmaceuticals, Inc.
4.61
undefined x undefined
undefined x undefined
bid
ask
-
0.18
3.76%
04:00 PM
timesize
| Ytd | 41.41% | |
| 1y | -11.52% |
4.55
day range
4.80
3.14
52 week range
14.80
| Open | 4.80 | Prev Close | 4.79 | Low | 4.55 | High | 4.80 | Mkt Cap | 2.96M |
| Vol | 2.38M | Avg Vol | 18.01K | EPS | -6.64 | P/E | N/A | Forward P/E | -3.56 |
| Beta | 1.13 | Short Ratio | 0.66 | Inst. Own | 1.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.97 | 200-d Avg | 5.73 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 657.00K | ||
| Selling, General and Administrative Expense | 657.00K | ||
| Operating Income | -657.00K | ||
| Net Income | -689.00K | ||
| Net Income Common Stock | -689.00K | ||
| Net Income Common Stock (USD) | -689.00K | ||
| Consolidated Income | -689.00K | ||
| Earnings per Basic Share | -0.65 | ||
| Earnings per Basic Share (USD) | -0.65 | ||
| Earnings per Diluted Share | -0.65 | ||
| Earning Before Interest & Taxes (EBIT) | -689.00K | ||
| Earning Before Interest & Taxes (USD) | -689.00K | ||
| Weighted Average Shares | 1.07M | ||
| Weighted Average Shares Diluted | 1.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.80M | ||
| Cash and Equivalents (USD) | 2.80M | ||
| Trade and Non-Trade Receivables | 143.00K | ||
| Current Assets | 3.05M | ||
| Total Assets | 3.05M | ||
| Current Liabilities | 263.00K | ||
| Total Liabilities | 263.00K | ||
| Accumulated Retained Earnings (Deficit) | -397.79M | ||
| Shareholders Equity | 2.79M | ||
| Shareholders Equity (USD) | 2.79M | ||
| Trade and Non-Trade Payables | 219.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.54M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 858.00K | ||
| Issuance (Repayment) of Debt Securities | -62.00K | ||
| Net Cash Flow from Operations | -680.00K | ||